EMEA-002127-PIP01-17-M01
Key facts
| Active substance |
Temelimab
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0313/2021
|
| PIP number |
EMEA-002127-PIP01-17-M01
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of multiple sclerosis
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
GeNeuro SA
Tel. +41 225524800 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|